Clinical Trials

945 enrolled 19 charts

Melanoma

NCT03551626 2025-04-29

COMBI-APlus

552 enrolled 12 charts

Fever, Melanoma

NCT02388906 2025-04-24

CheckMate 238

906 enrolled 16 charts 1 FDA

Melanoma

NCT03635983 2025-04-01

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma

783 enrolled 24 charts

Phase 3 Active not recruiting

Melanoma

NCT03553836 2024-11-29

KEYNOTE-716

976 enrolled 15 charts 1 FDA

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT03233828 2024-07-24

IL-2

1 enrolled 3 charts

Melanoma

NCT01682083 2023-08-30

COMBI-AD

870 enrolled 13 charts 1 FDA

Melanoma, Neoplasms

NCT04410445 2023-04-21

PIVOT-12

765 enrolled 13 charts

Melanoma, Skin Neoplasms

NCT01359956 2023-04-11

SICOG 0109

269 enrolled 12 charts

Melanoma

NCT03294330 2023-01-12

SPYX

35 enrolled 9 charts

BreastDermatologic

Breast Neoplasms, Melanoma

NCT03445533 2022-11-08

A Study of Tilsotolimod in Combo With Ipilimumab vs Ipilimumab Alone in Subjects With Anti-PD-1 Refractory Melanoma

481 enrolled 22 charts

Diabetes Mellitus, Insulin-Dependent, 12, Melanoma, Neoplasm Metastasis, Skin Neoplasms

NCT01721772 2022-07-12

CheckMate 066

418 enrolled 16 charts

Melanoma

NCT02714218 2022-06-24

A Study of Two Different Dose Combinations of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated, Unresectable or Metastatic Melanoma

387 enrolled 28 charts

Melanoma

NCT01689519 2022-05-02

coBRIM

495 enrolled 15 charts

Melanoma

NCT01721746 2022-04-19

A Study to Compare BMS-936558 to the Physician's Choice of Either Dacarbazine or Carboplatin and Paclitaxel in Advanced Melanoma Patients That Have Progressed Following Anti-CTLA-4 Therapy (CheckMate 037)

405 enrolled 16 charts

Melanoma

NCT02288897 2022-01-19

PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma

20 enrolled 13 charts

Melanoma, Recurrence

NCT03068455 2021-09-20

CheckMate 915

1,844 enrolled 14 charts

Melanoma

NCT02599402 2021-06-15

CheckMate 401

533 enrolled 19 charts

Melanoma

NCT01763164 2021-03-22

Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma

402 enrolled 21 charts

Melanoma, Neoplasm Metastasis, Skin Diseases, Skin Neoplasms

NCT01584648 2021-02-17

A Study Comparing Trametinib and Dabrafenib Combination Therapy to Dabrafenib Monotherapy in Subjects With BRAF-mutant Melanoma

423 enrolled 15 charts

Melanoma

NCT01989572 2020-07-07

Sargramostim, Vaccine Therapy, or Sargramostim and Vaccine Therapy in Preventing Disease Recurrence in Patients With Melanoma That Has Been Removed By Surgery

815 enrolled 10 charts

Uveal Melanoma, Melanoma

NCT01866319 2020-06-02

MK-3475-006

834 enrolled 13 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Melanoma

NCT02545075 2020-05-19

A Comparative Study in Chinese Subjects With Chemotherapy Naïve Stage IV Melanoma Receiving Ipilimumab (3 mg/kg) vs. Dacarbazine

182 enrolled 20 charts

Melanoma

NCT00864253 2019-10-30

A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma

529 enrolled 22 charts

Melanoma

NCT01667419 2019-07-23

BRIM8

498 enrolled 16 charts

Melanoma

NCT00540969 2018-11-21

Cryoablation or External-Beam Radiation Therapy in Treating Patients With Painful Bone Metastases

DermatologicGenitourinary

3 enrolled 1 chart

Carcinoma, Renal Cell, Kidney Neoplasms, Melanoma, Neoplasm Metastasis, Pain

NCT01245062 2018-04-05

GSK1120212 vs Chemotherapy in Advanced or Metastatic BRAF V600E/K Mutation-positive Melanoma

322 enrolled 24 charts

Melanoma, Neoplasms

NCT00019682 2017-11-20

Aldesleukin With or Without Vaccine Therapy in Treating Patients With Locally Advanced or Metastatic Melanoma

185 enrolled 11 charts

Melanoma

NCT01227889 2017-10-04

A Study Comparing GSK2118436 to Dacarbazine (DTIC) in Previously Untreated Subjects With BRAF Mutation Positive Advanced (Stage III) or Metastatic (Stage IV) Melanoma

251 enrolled 21 charts

Melanoma, Neoplasms

NCT00091572 2017-06-06

Temozolomide Versus Dacarbazine in Stage IV Metastatic Melanoma (Study P03267)

859 enrolled 11 charts

Melanoma

NCT01006980 2016-09-28

A Study of Vemurafenib (RO5185426) in Comparison With Dacarbazine in Previously Untreated Patients With Metastatic Melanoma (BRIM 3)

675 enrolled 14 charts

Melanoma

NCT00110019 2015-10-19

Carboplatin and Paclitaxel With or Without Sorafenib Tosylate in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery

823 enrolled 9 charts

Melanoma

NCT00006237 2015-03-25

S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma

432 enrolled 7 charts

Melanoma

NCT00111007 2014-10-31

A Treatment Combination for Patients With Unresectable Stage III or Stage IV Melanoma

270 enrolled 15 charts